cinacalcet
Selected indexed studies
- Hypocalcemia and cardiovascular mortality in cinacalcet users. (Nephrol Dial Transplant, 2024) [PMID:37777840]
- Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review. (Front Endocrinol (Lausanne), 2023) [PMID:37538795]
- Cinacalcet hydrochloride. (Drugs, 2005) [PMID:15631545]
_Worker-drafted node — pending editorial review._
Connections
cinacalcet is a side effect of
Sources
- Hypocalcemia and cardiovascular mortality in cinacalcet users. (2024) pubmed
- Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review. (2023) pubmed
- Cinacalcet hydrochloride. (2005) pubmed
- Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis. (2020) pubmed
- Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. (2017) pubmed
- Cinacalcet Hydrochloride. (2017) pubmed
- Cinacalcet Treatment Significantly Improves All-Cause and Cardiovascular Survival in Dialysis Patients: Results from a Meta-Analysis. (2019) pubmed
- Cinacalcet and Clinical Outcomes in Dialysis. (2015) pubmed
- Impact of Cinacalcet and Etelcalcetide on Bone Mineral and Cardiovascular Disease in Dialysis Patients. (2023) pubmed
- Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ? (2018) pubmed